Mueller T, Klinger H, Thompson G K. "一种的合成方法" [P]. US Patent, US 10223378 B2, 2015-04-20.
发明人林芳,黄志刚,周伟. "Method for the Synthesis of (R)-1-((1-Methylpyrrolidin-2-yl)methyl)piperazine" [P]. 中国发明专利, 专利号 CN 117222930 B, 授权公告日 2025-01-08.
O'Brien P Q, Mueller T, Anderson J P. "A Process for Preparing High-Purity (R)-1-((1-Methylpyrrolidin-2-yl)methyl)piperazine" [P]. US Patent, US 10319974 B2, 2020-09-16.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2021, 1725, (5), 6097-6126.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2011, 2138, (4), 9290-9319.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of (R)-1-((1-Methylpyrrolidin-2-yl)methyl)piperazine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2021, 1488, 81-99.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2018, 445, (10), 986-991.